USC’s Center for Advanced Lung Disease and the Division of Pulmonary, Critical Care and Sleep Medicine have developed a pulmonary hypertension program for the evaluation and treatment of patients with primary and secondary forms of pulmonary hypertension, or high blood pressure in the arteries that supply the lungs. The Pulmonary Hypertension Center offers a multi-disciplinary team of specialists and a full-range of treatment options for patients with pulmonary vascular disease and advanced heart failure.

The center offers comprehensive evaluation and testing for patients suspected of having underlying pulmonary hypertension. Our expert physicians provide state-of-the-art care while maintaining a personal approach to improve both length and quality of life.

What is pulmonary hypertension?

Pulmonary hypertension is a rare and serious blood vessel disorder of the lungs. It is a complex health disorder that is caused by elevated blood pressure within the lungs, which can lead to heart failure. This disease affects people of all ages and ethnic backgrounds. Frequently patients with pulmonary hypertension are not recognized until they have advanced disease because early symptoms can be confused with those of many other conditions. A higher awareness, earlier diagnosis and development of a comprehensive treatment plan can improve quality of life and prognosis in this life-threatening condition.

Our clinics are staffed by pulmonary physicians and other specialists.

Physicians at the Pulmonary Hypertension Center treat a wide range of conditions, including:
• Pulmonary arterial hypertension (PAH)
◦ Idiopathic
◦ Familial
◦ Pulmonary hypertension associated with connective tissue disorder, congenital heart disease, portal hypertension, HIV infection, drugs and toxins, thyroid disorders, glycogen storage disease, Gaucher’s disease, hereditary hemorrhagic telangiectasia, hemoglobinopathies, chronic myeloproliferative disorders and splenectomy
• Pulmonary hypertension with left heart disease
• Pulmonary hypertension associated with lung diseases and/or hypoxemia
• Pulmonary hypertension due to chronic thrombotic and/or embolic
• Miscellaneous issues—sarcoidosis, histiocytoss X, lumphangiomatosis, compression of pulmonary vessels (adenopathy, tumor, fibrosing mediastinitis)